“C” to Believe: Jefferson Scientists Studying the Effects of High Dose Vitamin C on Non-Hodgkin Lymphoma Patients

Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether …

Page 1 of 24